Skip to content
Open Data Finder
Open Government Canada

Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements

Published by Health Canada | Santé Canada

About this dataset

COVID-19 drugs must be manufactured under good manufacturing practices (GMP) conditions. These conditions must be in line with the international requirements outlined in the International Council for Harmonization Q7A guideline and with applicable Health Canada's guidance.

Guidance for market authorization requirements for COVID-19 drugs: Quality and manufact… · Open Data Finder